{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:53:42Z","timestamp":1794696822266,"version":"4.9.1"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008084","name":"Neuroforbundet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008084","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA013330 NCI Cancer Center Grant"],"award-info":[{"award-number":["P30CA013330 NCI Cancer Center Grant"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA013330"],"award-info":[{"award-number":["P30CA013330"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["U54 HD090260 support for the Rose F. Kennedy"],"award-info":[{"award-number":["U54 HD090260 support for the Rose F. Kennedy"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["U54 HD090260"],"award-info":[{"award-number":["U54 HD090260"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["Grant R01NS091519"],"award-info":[{"award-number":["Grant R01NS091519"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"David and Ruth Levine Fund"},{"name":"the Haworth Family Professorship in Neurodegenerative Diseases Fund"},{"DOI":"10.13039\/100016295","name":"The Sol Goldman Charitable Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016295","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mayo Clinic Center for Regenerative Medicine","id":[{"id":"https:\/\/ror.org\/02qp3tb03","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Albertson Parkinson\u2019s Research Foundation"},{"name":"the Donald G. and Jodi P. Heeringa Family"},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alltid Lite Sterkere"},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microglia are specialized dynamic immune cells in the central nervous system (CNS) that plays a crucial role in brain homeostasis and in disease states. Persistent neuroinflammation is considered a hallmark of many neurodegenerative diseases, including Alzheimer\u2019s disease (AD), Parkinson's disease (PD), Huntington\u2019s disease (HD), amyotrophic lateral sclerosis (ALS) and primary progressive multiple sclerosis (MS). Colony stimulating factor 1-receptor (CSF-1R) is predominantly expressed on microglia and its expression is significantly increased in neurodegenerative diseases. Cumulative findings have indicated that CSF-1R inhibitors can have beneficial effects in preclinical neurodegenerative disease models. Research using CSF-1R inhibitors has now been extended into non-human primates and humans. This review article summarizes the most recent advances using CSF-1R inhibitors in different neurodegenerative conditions including AD, PD, HD, ALS and MS. Potential challenges for translating these findings into clinical practice are presented.<\/jats:p>","DOI":"10.1007\/s00018-022-04225-1","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:03:27Z","timestamp":1648865007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges"],"prefix":"10.1007","volume":"79","author":[{"given":"Jinming","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Chitu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Richard","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-8951","authenticated-orcid":false,"given":"Virginija Danylait\u00e9","family":"Karrenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"issue":"6005","key":"4225_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER et al (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330(6005):841\u2013845","journal-title":"Science"},{"issue":"2","key":"4225_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","volume":"179","author":"M Prinz","year":"2019","unstructured":"Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179(2):292\u2013311","journal-title":"Cell"},{"issue":"11","key":"4225_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.tins.2019.09.004","volume":"42","author":"A Sierra","year":"2019","unstructured":"Sierra A, Paolicelli RC, Kettenmann H (2019) Cien anos de microglia: milestones in a century of microglial research. Trends Neurosci 42(11):778\u2013792","journal-title":"Trends Neurosci"},{"key":"4225_CR4","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.pneurobio.2019.04.003","volume":"179","author":"UB Eyo","year":"2019","unstructured":"Eyo UB, Wu LJ (2019) Microglia: lifelong patrolling immune cells of the brain. Prog Neurobiol 179:101614","journal-title":"Prog Neurobiol"},{"issue":"3","key":"4225_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-017-1747-1","volume":"134","author":"N Hagemeyer","year":"2017","unstructured":"Hagemeyer N, Hanft KM, Akriditou MA, Unger N, Park ES, Stanley ER, Staszewski O, Dimou L, Prinz M (2017) Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol 134(3):441\u2013458","journal-title":"Acta Neuropathol"},{"key":"4225_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.conb.2015.12.004","volume":"36","author":"S Hong","year":"2016","unstructured":"Hong S, Dissing-Olesen L, Stevens B (2016) New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 36:128\u2013134","journal-title":"Curr Opin Neurobiol"},{"issue":"7","key":"4225_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276-1290 e1217","journal-title":"Cell"},{"issue":"2","key":"4225_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2017.09.039","volume":"21","author":"H Mathys","year":"2017","unstructured":"Mathys H, Adaikkan C, Gao F, Young JZ, Manet E, Hemberg M, De Jager PL, Ransohoff RM, Regev A, Tsai LH (2017) Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep 21(2):366\u2013380","journal-title":"Cell Rep"},{"issue":"3","key":"4225_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019Loughlin E, Xu Y, Fanek Z et al (2017) The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47(3):566-581 e569","journal-title":"Immunity"},{"key":"4225_CR10","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0860-21.2021","author":"R Hakim","year":"2021","unstructured":"Hakim R, Zachariadis V, Sankavaram SR, Han J, Harris RA, Brundin L, Enge M, Svensson M (2021) Spinal cord injury induces permanent re-programming of microglia into a disease-associated state which contributes to functional recovery. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.0860-21.2021","journal-title":"J Neurosci"},{"issue":"3","key":"4225_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, Cao Y, Lee SH, Haddick PCG, Ngu H et al (2018) Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep 22(3):832\u2013847","journal-title":"Cell Rep"},{"issue":"8","key":"4225_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","volume":"21","author":"P Ayata","year":"2018","unstructured":"Ayata P, Badimon A, Strasburger HJ, Duff MK, Montgomery SE, Loh YE, Ebert A, Pimenova AA, Ramirez BR, Chan AT et al (2018) Epigenetic regulation of brain region-specific microglia clearance activity. Nat Neurosci 21(8):1049\u20131060","journal-title":"Nat Neurosci"},{"issue":"9","key":"4225_CR13","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1016\/j.celrep.2020.02.028","volume":"30","author":"V Chitu","year":"2020","unstructured":"Chitu V, Biundo F, Shlager GGL, Park ES, Wang P, Gulinello ME, Gokhan S, Ketchum HC, Saha K, DeTure MA et al (2020) Microglial homeostasis requires balanced CSF-1\/CSF-2 receptor signaling. Cell Rep 30(9):3004-3019 e3005","journal-title":"Cell Rep"},{"issue":"8","key":"4225_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE (2019) The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol 15(8):447\u2013458","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"4225_CR15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4103\/1673-5374.255359","volume":"14","author":"W Gomes-Leal","year":"2019","unstructured":"Gomes-Leal W (2019) Why microglia kill neurons after neural disorders? The friendly fire hypothesis. Neural Regen Res 14(9):1499\u20131502","journal-title":"Neural Regen Res"},{"issue":"10","key":"4225_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41419-020-03084-7","volume":"11","author":"N Hagan","year":"2020","unstructured":"Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, Sancho J, Liu J, Li Y, Proto J et al (2020) CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis 11(10):904","journal-title":"Cell Death Dis"},{"key":"4225_CR17","doi-asserted-by":"publisher","first-page":"101970","DOI":"10.1016\/j.pneurobio.2020.101970","volume":"200","author":"F Mesquida-Veny","year":"2021","unstructured":"Mesquida-Veny F, Del Rio JA, Hervera A (2021) Macrophagic and microglial complexity after neuronal injury. Prog Neurobiol 200:101970","journal-title":"Prog Neurobiol"},{"issue":"1","key":"4225_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01099-x","volume":"9","author":"A Sobue","year":"2021","unstructured":"Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, Murayama S, Saito T, Saido TC, Sahara N et al (2021) Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer\u2019s disease. Acta Neuropathol Commun 9(1):1","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4225_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s40478-020-01047-9","volume":"8","author":"MEV Swanson","year":"2020","unstructured":"Swanson MEV, Scotter EL, Smyth LCD, Murray HC, Ryan B, Turner C, Faull RLM, Dragunow M, Curtis MA (2020) Identification of a dysfunctional microglial population in human Alzheimer\u2019s disease cortex using novel single-cell histology image analysis. Acta Neuropathol Commun 8(1):170","journal-title":"Acta Neuropathol Commun"},{"key":"4225_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26032","author":"MS Andersen","year":"2021","unstructured":"Andersen MS, Bandres-Ciga S, Reynolds RH, Hardy J, Ryten M, Krohn L, Gan-Or Z, Holtman IR, International Parkinson\u2019s Disease Genomics C, Pihlstrom L (2021) Heritability enrichment implicates microglia in Parkinson\u2019s disease pathogenesis. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.26032","journal-title":"Ann Neurol"},{"issue":"1","key":"4225_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12974-020-01782-9","volume":"17","author":"JC Savage","year":"2020","unstructured":"Savage JC, St-Pierre MK, Carrier M, El Hajj H, Novak SW, Sanchez MG, Cicchetti F, Tremblay ME (2020) Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington\u2019s disease pathology. J Neuroinflammation 17(1):98","journal-title":"J Neuroinflammation"},{"issue":"21","key":"4225_CR22","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.3390\/ijms21217923","volume":"21","author":"G Cipollina","year":"2020","unstructured":"Cipollina G, Davari Serej A, Di Nolfi G, Gazzano A, Marsala A, Spatafora MG, Peviani M (2020) Heterogeneity of Neuroinflammatory responses in amyotrophic lateral sclerosis: a challenge or an opportunity? Int J Mol Sci 21(21):7923","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4225_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/ijms22030993","volume":"22","author":"H Cihankaya","year":"2021","unstructured":"Cihankaya H, Theiss C, Matschke V (2021) Little helpers or mean rogue-role of microglia in animal models of amyotrophic lateral sclerosis. Int J Mol Sci 22(3):993","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4225_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s40478-020-01010-8","volume":"8","author":"C Bottcher","year":"2020","unstructured":"Bottcher C, van der Poel M, Fernandez-Zapata C, Schlickeiser S, Leman JKH, Hsiao CC, Mizee MR, Adelia, Vincenten MCJ, Kunkel D et al (2020) Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis. Acta Neuropathol Commun 8(1):136","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"4225_CR25","doi-asserted-by":"publisher","first-page":"e587","DOI":"10.1212\/NXI.0000000000000587","volume":"6","author":"T Singhal","year":"2019","unstructured":"Singhal T, O\u2019Connor K, Dubey S, Pan H, Chu R, Hurwitz S, Cicero S, Tauhid S, Silbersweig D, Stern E et al (2019) Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study. Neurol Neuroimmunol Neuroinflamm 6(5):e587","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"4225_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/ijms20010081","volume":"20","author":"CM Wolfe","year":"2018","unstructured":"Wolfe CM, Fitz NF, Nam KN, Lefterov I, Koldamova R (2018) The role of APOE and TREM2 in Alzheimer\u2019s disease-current understanding and perspectives. Int J Mol Sci 20(1):81","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4225_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/glia.23529","volume":"67","author":"J Han","year":"2019","unstructured":"Han J, Zhu K, Zhang XM, Harris RA (2019) Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders. Glia 67(2):217\u2013231","journal-title":"Glia"},{"issue":"1","key":"4225_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13041-017-0307-x","volume":"10","author":"J Han","year":"2017","unstructured":"Han J, Harris RA, Zhang XM (2017) An updated assessment of microglia depletion: current concepts and future directions. Mol Brain 10(1):25","journal-title":"Mol Brain"},{"issue":"1","key":"4225_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s40478-020-01093-3","volume":"8","author":"J Han","year":"2020","unstructured":"Han J, Sarlus H, Wszolek ZK, Karrenbauer VD, Harris RA (2020) Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy. Acta Neuropathol Commun 8(1):217","journal-title":"Acta Neuropathol Commun"},{"key":"4225_CR30","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021857","author":"ER Stanley","year":"2014","unstructured":"Stanley ER, Chitu V (2014) CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a021857","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"30","key":"4225_CR31","doi-asserted-by":"publisher","first-page":"21972","DOI":"10.1074\/jbc.M112.442731","volume":"288","author":"S Nandi","year":"2013","unstructured":"Nandi S, Cioce M, Yeung YG, Nieves E, Tesfa L, Lin H, Hsu AW, Halenbeck R, Cheng HY, Gokhan S et al (2013) Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34. J Biol Chem 288(30):21972\u201321986","journal-title":"J Biol Chem"},{"issue":"10","key":"4225_CR32","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1084\/jem.20182037","volume":"216","author":"V Kana","year":"2019","unstructured":"Kana V, Desland FA, Casanova-Acebes M, Ayata P, Badimon A, Nabel E, Yamamuro K, Sneeboer M, Tan IL, Flanigan ME et al (2019) CSF-1 controls cerebellar microglia and is required for motor function and social interaction. J Exp Med 216(10):2265\u20132281","journal-title":"J Exp Med"},{"issue":"8","key":"4225_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, Barrow AD, Diamond MS, Colonna M (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 13(8):753\u2013760","journal-title":"Nat Immunol"},{"issue":"6","key":"4225_CR34","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.immuni.2012.11.001","volume":"37","author":"M Greter","year":"2012","unstructured":"Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, Kundig TM, Frei K, Ginhoux F, Merad M et al (2012) Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 37(6):1050\u20131060","journal-title":"Immunity"},{"issue":"4","key":"4225_CR35","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.7150\/thno.50683","volume":"11","author":"J Munoz-Garcia","year":"2021","unstructured":"Munoz-Garcia J, Cochonneau D, Teletchea S, Moranton E, Lanoe D, Brion R, Lezot F, Heymann MF, Heymann D (2021) The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis. Theranostics 11(4):1568\u20131593","journal-title":"Theranostics"},{"key":"4225_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.ctdb.2016.10.004","volume":"123","author":"V Chitu","year":"2017","unstructured":"Chitu V, Stanley ER (2017) Regulation of embryonic and postnatal development by the CSF-1 receptor. Curr Top Dev Biol 123:229\u2013275","journal-title":"Curr Top Dev Biol"},{"issue":"2","key":"4225_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1440-1789.2000.00286.x","volume":"20","author":"A Sasaki","year":"2000","unstructured":"Sasaki A, Yokoo H, Naito M, Kaizu C, Shultz LD, Nakazato Y (2000) Effects of macrophage-colony-stimulating factor deficiency on the maturation of microglia and brain macrophages and on their expression of scavenger receptor. Neuropathology 20(2):134\u2013142","journal-title":"Neuropathology"},{"issue":"12","key":"4225_CR38","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/jnr.22096","volume":"87","author":"Y Kondo","year":"2009","unstructured":"Kondo Y, Duncan ID (2009) Selective reduction in microglia density and function in the white matter of colony-stimulating factor-1-deficient mice. J Neurosci Res 87(12):2686\u20132695","journal-title":"J Neurosci Res"},{"key":"4225_CR39","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.3389\/fimmu.2019.02199","volume":"10","author":"C Easley-Neal","year":"2019","unstructured":"Easley-Neal C, Foreman O, Sharma N, Zarrin AA, Weimer RM (2019) CSF1R ligands IL-34 and CSF1 are differentially required for microglia development and maintenance in white and gray matter brain regions. Front Immunol 10:2199","journal-title":"Front Immunol"},{"issue":"2","key":"4225_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1248\/bpb.b19-00694","volume":"43","author":"N Uesato","year":"2020","unstructured":"Uesato N, Miyagawa N, Inagaki K, Kakefuda R, Kitagawa Y, Matsuo Y, Yamaguchi T, Hata T, Ikegashira K, Matsushita M (2020) Pharmacological properties of JTE-952, an orally available and selective colony stimulating factor 1 receptor kinase inhibitor. Biol Pharm Bull 43(2):325\u2013333","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"4225_CR41","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s000110050638","volume":"49","author":"JT Murray","year":"2000","unstructured":"Murray JT, Craggs G, Wilson L, Kellie S (2000) Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis. Inflamm Res 49(11):610\u2013618","journal-title":"Inflamm Res"},{"issue":"37","key":"4225_CR42","doi-asserted-by":"publisher","first-page":"26393","DOI":"10.1074\/jbc.274.37.26393","volume":"274","author":"TW Kelley","year":"1999","unstructured":"Kelley TW, Graham MM, Doseff AI, Pomerantz RW, Lau SM, Ostrowski MC, Franke TF, Marsh CB (1999) Macrophage colony-stimulating factor promotes cell survival through Akt\/protein kinase B. J Biol Chem 274(37):26393\u201326398","journal-title":"J Biol Chem"},{"issue":"3","key":"4225_CR43","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1158\/1078-0432.CCR-19-1486","volume":"26","author":"C Murga-Zamalloa","year":"2020","unstructured":"Murga-Zamalloa C, Rolland DCM, Polk A, Wolfe A, Dewar H, Chowdhury P, Onder O, Dewar R, Brown NA, Bailey NG et al (2020) Colony-stimulating factor 1 receptor (CSF1R) activates AKT\/mTOR signaling and promotes T-cell lymphoma viability. Clin Cancer Res 26(3):690\u2013703","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4225_CR44","doi-asserted-by":"publisher","first-page":"e26317","DOI":"10.1371\/journal.pone.0026317","volume":"6","author":"B Erblich","year":"2011","unstructured":"Erblich B, Zhu L, Etgen AM, Dobrenis K, Pollard JW (2011) Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One 6(10):e26317","journal-title":"PLoS One"},{"issue":"2","key":"4225_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL et al (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82(2):380\u2013397","journal-title":"Neuron"},{"issue":"5","key":"4225_CR46","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajhg.2019.03.010","volume":"104","author":"N Oosterhof","year":"2019","unstructured":"Oosterhof N, Chang IJ, Karimiani EG, Kuil LE, Jensen DM, Daza R, Young E, Astle L, van der Linde HC, Shivaram GM et al (2019) Homozygous mutations in CSF1R cause a pediatric-onset leukoencephalopathy and can result in congenital absence of microglia. Am J Hum Genet 104(5):936\u2013947","journal-title":"Am J Hum Genet"},{"issue":"15","key":"4225_CR47","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.3390\/ijms21155553","volume":"21","author":"Y Son","year":"2020","unstructured":"Son Y, Jeong YJ, Shin NR, Oh SJ, Nam KR, Choi HD, Choi JY, Lee HJ (2020) Inhibition of colony-stimulating factor 1 receptor by PLX3397 prevents amyloid beta pathology and rescues dopaminergic signaling in aging 5xFAD mice. Int J Mol Sci 21(15):5553","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4225_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7150\/thno.35841","volume":"10","author":"LY Zhang","year":"2020","unstructured":"Zhang LY, Pan J, Mamtilahun M, Zhu Y, Wang L, Venkatesh A, Shi R, Tu X, Jin K, Wang Y et al (2020) Microglia exacerbate white matter injury via complement C3\/C3aR pathway after hypoperfusion. Theranostics 10(1):74\u201390","journal-title":"Theranostics"},{"issue":"3","key":"4225_CR49","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.18632\/aging.102724","volume":"12","author":"S Ali","year":"2020","unstructured":"Ali S, Mansour AG, Huang W, Queen NJ, Mo X, Anderson JM, Hassan Ii QN, Patel RS, Wilkins RK, Caligiuri MA et al (2020) CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice. Aging (Albany NY) 12(3):2101\u20132122","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"4225_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40478-018-0510-8","volume":"6","author":"N Beckmann","year":"2018","unstructured":"Beckmann N, Giorgetti E, Neuhaus A, Zurbruegg S, Accart N, Smith P, Perdoux J, Perrot L, Nash M, Desrayaud S et al (2018) Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945. Acta Neuropathol Commun 6(1):9","journal-title":"Acta Neuropathol Commun"},{"key":"4225_CR51","doi-asserted-by":"publisher","first-page":"8825954","DOI":"10.1155\/2020\/8825954","volume":"2020","author":"X Du","year":"2020","unstructured":"Du X, Xu Y, Chen S, Fang M (2020) Inhibited CSF1R alleviates ischemia injury via inhibition of microglia M1 polarization and NLRP3 pathway. Neural Plast 2020:8825954","journal-title":"Neural Plast"},{"issue":"1\u20132","key":"4225_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2008.01.015","volume":"195","author":"Y Uemura","year":"2008","unstructured":"Uemura Y, Ohno H, Ohzeki Y, Takanashi H, Murooka H, Kubo K, Serizawa I (2008) The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol 195(1\u20132):73\u201380","journal-title":"J Neuroimmunol"},{"issue":"10","key":"4225_CR53","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monzon-Sandoval J, Ribe E, Winchester L, Webber C, Nevado A et al (2019) CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142(10):3243\u20133264","journal-title":"Brain"},{"issue":"1","key":"4225_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"MA Cannarile","year":"2017","unstructured":"Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Ruttinger D (2017) Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer 5(1):53","journal-title":"J Immunother Cancer"},{"key":"4225_CR55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fncel.2018.00368","volume":"12","author":"YN Gerber","year":"2018","unstructured":"Gerber YN, Saint-Martin GP, Bringuier CM, Bartolami S, Goze-Bac C, Noristani HN, Perrin FE (2018) CSF1R inhibition reduces microglia proliferation, promotes tissue preservation and improves motor recovery after spinal cord injury. Front Cell Neurosci 12:368","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"4225_CR56","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s10875-011-9579-6","volume":"31","author":"O Crespo","year":"2011","unstructured":"Crespo O, Kang SC, Daneman R, Lindstrom TM, Ho PP, Sobel RA, Steinman L, Robinson WH (2011) Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis. J Clin Immunol 31(6):1010\u20131020","journal-title":"J Clin Immunol"},{"issue":"Pt 4","key":"4225_CR57","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN (2016) Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology. Brain 139(Pt 4):1265\u20131281","journal-title":"Brain"},{"issue":"1","key":"4225_CR58","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W, Lin J, Phan NY et al (2019) Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun 10(1):3758","journal-title":"Nat Commun"},{"issue":"1","key":"4225_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13550-017-0305-0","volume":"7","author":"AT Hillmer","year":"2017","unstructured":"Hillmer AT, Holden D, Fowles K, Nabulsi N, West BL, Carson RE, Cosgrove KP (2017) Microglial depletion and activation: a [(11)C]PBR28 PET study in nonhuman primates. EJNMMI Res 7(1):59","journal-title":"EJNMMI Res"},{"issue":"5","key":"4225_CR60","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00280-020-04071-7","volume":"85","author":"PS Shankarappa","year":"2020","unstructured":"Shankarappa PS, Peer CJ, Odabas A, McCully CL, Garcia RC, Figg WD, Warren KE (2020) Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib. Cancer Chemother Pharmacol 85(5):1003\u20131007","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"4225_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/neuonc\/nov245","volume":"18","author":"N Butowski","year":"2016","unstructured":"Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A et al (2016) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro Oncol 18(4):557\u2013564","journal-title":"Neuro Oncol"},{"issue":"6","key":"4225_CR62","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1096\/fj.201700833RR","volume":"32","author":"X Yang","year":"2018","unstructured":"Yang X, Ren H, Wood K, Li M, Qiu S, Shi FD, Ma C, Liu Q (2018) Depletion of microglia augments the dopaminergic neurotoxicity of MPTP. FASEB J 32(6):3336\u20133345","journal-title":"FASEB J"},{"issue":"5","key":"4225_CR63","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1411366","volume":"373","author":"WD Tap","year":"2015","unstructured":"Tap WD, Wainberg ZA, Anthony SP, Ibrahim PN, Zhang C, Healey JH, Chmielowski B, Staddon AP, Cohn AL, Shapiro GI et al (2015) Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N Engl J Med 373(5):428\u2013437","journal-title":"N Engl J Med"},{"issue":"38","key":"4225_CR64","doi-asserted-by":"publisher","first-page":"23336","DOI":"10.1073\/pnas.1922788117","volume":"117","author":"F Lei","year":"2020","unstructured":"Lei F, Cui N, Zhou C, Chodosh J, Vavvas DG, Paschalis EI (2020) CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc Natl Acad Sci USA 117(38):23336\u201323338","journal-title":"Proc Natl Acad Sci USA"},{"key":"4225_CR65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2014.11.007","volume":"57","author":"SA Chalmers","year":"2015","unstructured":"Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C (2015) Macrophage depletion ameliorates nephritis induced by pathogenic antibodies. J Autoimmun 57:42\u201352","journal-title":"J Autoimmun"},{"issue":"9","key":"4225_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","volume":"41","author":"KN Green","year":"2020","unstructured":"Green KN, Crapser JD, Hohsfield LA (2020) To Kill a microglia: a case for CSF1R inhibitors. Trends Immunol 41(9):771\u2013784","journal-title":"Trends Immunol"},{"key":"4225_CR67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher NN, Najafi AR, Kayala KM, Elmore MR, White TE, Medeiros R, West BL, Green KN (2015) Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J Neuroinflammation 12:139","journal-title":"J Neuroinflammation"},{"issue":"44","key":"4225_CR68","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1073\/pnas.0502000102","volume":"102","author":"JG Conway","year":"2005","unstructured":"Conway JG, McDonald B, Parham J, Keith B, Rusnak DW, Shaw E, Jansen M, Lin P, Payne A, Crosby RM et al (2005) Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci USA 102(44):16078\u201316083","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"4225_CR69","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.3390\/ijms21228603","volume":"21","author":"J Han","year":"2020","unstructured":"Han J, Fan Y, Zhou K, Zhu K, Blomgren K, Lund H, Zhang XM, Harris RA (2020) Underestimated peripheral effects following pharmacological and conditional genetic microglial depletion. Int J Mol Sci 21(22):8603","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4225_CR70","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","volume":"21","author":"Y Huang","year":"2018","unstructured":"Huang Y, Xu Z, Xiong S, Sun F, Qin G, Hu G, Wang J, Zhao L, Liang YX, Wu T et al (2018) Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nat Neurosci 21(4):530\u2013540","journal-title":"Nat Neurosci"},{"issue":"6","key":"4225_CR71","doi-asserted-by":"publisher","first-page":"e12832","DOI":"10.1111\/acel.12832","volume":"17","author":"MRP Elmore","year":"2018","unstructured":"Elmore MRP, Hohsfield LA, Kramar EA, Soreq L, Lee RJ, Pham ST, Najafi AR, Spangenberg EE, Wood MA, West BL et al (2018) Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice. Aging Cell 17(6):e12832","journal-title":"Aging Cell"},{"issue":"5","key":"4225_CR72","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2020.02.013","volume":"180","author":"EF Willis","year":"2020","unstructured":"Willis EF, MacDonald KPA, Nguyen QH, Garrido AL, Gillespie ER, Harley SBR, Bartlett PF, Schroder WA, Yates AG, Anthony DC et al (2020) Repopulating microglia promote brain repair in an IL-6-dependent manner. Cell 180(5):833-846 e816","journal-title":"Cell"},{"issue":"1","key":"4225_CR73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13195-017-0294-2","volume":"9","author":"C Wattmo","year":"2017","unstructured":"Wattmo C, Wallin AK (2017) Early- versus late-onset Alzheimer\u2019s disease in clinical practice: cognitive and global outcomes over 3 years. Alzheimers Res Ther 9(1):70","journal-title":"Alzheimers Res Ther"},{"issue":"22","key":"4225_CR74","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.3390\/ijms21228661","volume":"21","author":"B Zhou","year":"2020","unstructured":"Zhou B, Fukushima M (2020) Clinical utility of the pathogenesis-related proteins in Alzheimer\u2019s disease. Int J Mol Sci 21(22):8861","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4225_CR75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","volume":"6","author":"J Neddens","year":"2018","unstructured":"Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T, Niederkofler V, Daum G, Attems J, Hutter-Paier B (2018) Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):52","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"4225_CR76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389\u2013404","journal-title":"Acta Neuropathol"},{"issue":"40","key":"4225_CR77","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L et al (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26(40):10129\u201310140","journal-title":"J Neurosci"},{"issue":"1","key":"4225_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R 3rd, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, Glabe CG (2018) Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener 13(1):11","journal-title":"Mol Neurodegener"},{"key":"4225_CR79","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer WA, Vassar R (2013) Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Mol Neurodegener 8:2","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4225_CR80","doi-asserted-by":"publisher","first-page":"196 e129","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O (2012) Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 33(1):196 e129\u2013140","journal-title":"Neurobiol Aging"},{"issue":"3","key":"4225_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172","journal-title":"Nat Rev Neurol"},{"key":"4225_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228751","author":"S Sanchez-Sarasua","year":"2020","unstructured":"Sanchez-Sarasua S, Fernandez-Perez I, Espinosa-Fernandez V, Sanchez-Perez AM, Ledesma JC (2020) Can we treat neuroinflammation in Alzheimer\u2019s disease? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228751","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4225_CR83","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s40478-020-00989-4","volume":"8","author":"J Michael","year":"2020","unstructured":"Michael J, Unger MS, Poupardin R, Schernthaner P, Mrowetz H, Attems J, Aigner L (2020) Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer\u2019s Disease mice. Acta Neuropathol Commun 8(1):129","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4225_CR84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","volume":"11","author":"X Wang","year":"2015","unstructured":"Wang X, Zhu M, Hjorth E, Cortes-Toro V, Eyjolfsdottir H, Graff C, Nennesmo I, Palmblad J, Eriksdotter M, Sambamurti K et al (2015) Resolution of inflammation is altered in Alzheimer\u2019s disease. Alzheimers Dement 11(1):40\u201350","journal-title":"Alzheimers Dement"},{"key":"4225_CR85","doi-asserted-by":"publisher","first-page":"175628641879110","DOI":"10.1177\/1756286418791107","volume":"11","author":"M Zhu","year":"2018","unstructured":"Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E (2018) Can inflammation be resolved in Alzheimer\u2019s disease? Ther Adv Neurol Disord 11:1756286418791107","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"4225_CR86","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977\u20131981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5123","key":"4225_CR87","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261(5123):921\u2013923","journal-title":"Science"},{"issue":"2","key":"4225_CR88","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127","journal-title":"N Engl J Med"},{"issue":"2","key":"4225_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116","journal-title":"N Engl J Med"},{"issue":"12","key":"4225_CR90","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/glia.23074","volume":"64","author":"SH Baik","year":"2016","unstructured":"Baik SH, Kang S, Son SM, Mook-Jung I (2016) Microglia contributes to plaque growth by cell death due to uptake of amyloid beta in the brain of Alzheimer\u2019s disease mouse model. Glia 64(12):2274\u20132290","journal-title":"Glia"},{"key":"4225_CR91","doi-asserted-by":"publisher","first-page":"104956","DOI":"10.1016\/j.nbd.2020.104956","volume":"142","author":"BT Casali","year":"2020","unstructured":"Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE (2020) Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiol Dis 142:104956","journal-title":"Neurobiol Dis"},{"issue":"Pt 3","key":"4225_CR92","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D (2016) Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain 139(Pt 3):891\u2013907","journal-title":"Brain"},{"issue":"11","key":"4225_CR93","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kugler S, Ikezu T (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584\u20131593","journal-title":"Nat Neurosci"},{"issue":"11","key":"4225_CR94","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J, Hoyle R, Holtzman DM (2019) Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med 216(11):2546\u20132561","journal-title":"J Exp Med"},{"issue":"1","key":"4225_CR95","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12974-018-1348-5","volume":"15","author":"RE Bennett","year":"2018","unstructured":"Bennett RE, Bryant A, Hu M, Robbins AB, Hopp SC, Hyman BT (2018) Partial reduction of microglia does not affect tau pathology in aged mice. J Neuroinflammation 15(1):311","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4225_CR96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1084\/jem.20120412","volume":"210","author":"J Luo","year":"2013","unstructured":"Luo J, Elwood F, Britschgi M, Villeda S, Zhang H, Ding Z, Zhu L, Alabsi H, Getachew R, Narasimhan R et al (2013) Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J Exp Med 210(1):157\u2013172","journal-title":"J Exp Med"},{"issue":"6","key":"4225_CR97","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tins.2016.03.005","volume":"39","author":"V Chitu","year":"2016","unstructured":"Chitu V, Gokhan S, Nandi S, Mehler MF, Stanley ER (2016) Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci 39(6):378\u2013393","journal-title":"Trends Neurosci"},{"key":"4225_CR98","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fnmol.2018.00410","volume":"11","author":"AJ Clare","year":"2018","unstructured":"Clare AJ, Day RC, Empson RM, Hughes SM (2018) Transcriptome Profiling of layer 5 intratelencephalic projection neurons from the mature mouse motor cortex. Front Mol Neurosci 11:410","journal-title":"Front Mol Neurosci"},{"key":"4225_CR99","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51796","author":"L Zhan","year":"2020","unstructured":"Zhan L, Fan L, Kodama L, Sohn PD, Wong MY, Mousa GA, Zhou Y, Li Y, Gan L (2020) A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain. Elife. https:\/\/doi.org\/10.7554\/eLife.51796","journal-title":"Elife"},{"issue":"9","key":"4225_CR100","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1474-4422(19)30195-4","volume":"18","author":"SY Lim","year":"2019","unstructured":"Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL, Bhidayasiri R, Wu YR, Shang HF, Evans AH et al (2019) Parkinson\u2019s disease in the Western Pacific region. Lancet Neurol 18(9):865\u2013879","journal-title":"Lancet Neurol"},{"key":"4225_CR101","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2021.0013","author":"LM Milanowski","year":"2021","unstructured":"Milanowski LM, Ross OA, Friedman A, Hoffman-Zacharska D, Gorka-Skoczylas P, Jurek M, Koziorowski D, Wszolek ZK (2021) Genetics of Parkinson\u2019s disease in the polish population. Neurol Neurochir Pol. https:\/\/doi.org\/10.5603\/PJNNS.a2021.0013","journal-title":"Neurol Neurochir Pol"},{"key":"4225_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071006","author":"JO Day","year":"2021","unstructured":"Day JO, Mullin S (2021) The genetics of Parkinson\u2019s disease and implications for clinical practice. Genes (Basel). https:\/\/doi.org\/10.3390\/genes12071006","journal-title":"Genes (Basel)"},{"issue":"Suppl 1","key":"4225_CR103","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):14\u201320","journal-title":"Eur J Neurol"},{"issue":"6","key":"4225_CR104","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"4225_CR105","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41593-019-0511-3","volume":"22","author":"YU Liu","year":"2019","unstructured":"Liu YU, Ying Y, Li Y, Eyo UB, Chen T, Zheng J, Umpierre AD, Zhu J, Bosco DB, Dong H et al (2019) Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nat Neurosci 22(11):1771\u20131781","journal-title":"Nat Neurosci"},{"issue":"7829","key":"4225_CR106","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-020-2777-8","volume":"586","author":"A Badimon","year":"2020","unstructured":"Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, Hwang P, Chan AT, Graves SM, Uweru JO et al (2020) Negative feedback control of neuronal activity by microglia. Nature 586(7829):417\u2013423","journal-title":"Nature"},{"key":"4225_CR107","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fncel.2018.00282","volume":"12","author":"C Lecours","year":"2018","unstructured":"Lecours C, Bordeleau M, Cantin L, Parent M, Paolo TD, Tremblay ME (2018) Microglial implication in Parkinson\u2019s disease: loss of beneficial physiological roles or gain of inflammatory functions? Front Cell Neurosci 12:282","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"4225_CR108","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57(2):168\u2013175","journal-title":"Ann Neurol"},{"key":"4225_CR109","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fnmol.2016.00089","volume":"9","author":"W Le","year":"2016","unstructured":"Le W, Wu J, Tang Y (2016) Protective microglia and their regulation in Parkinson\u2019s disease. Front Mol Neurosci 9:89","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"4225_CR110","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","volume":"14","author":"ME Tremblay","year":"2019","unstructured":"Tremblay ME, Cookson MR, Civiero L (2019) Glial phagocytic clearance in Parkinson\u2019s disease. Mol Neurodegener 14(1):16","journal-title":"Mol Neurodegener"},{"key":"4225_CR111","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fncel.2019.00514","volume":"13","author":"CY Liu","year":"2019","unstructured":"Liu CY, Wang X, Liu C, Zhang HL (2019) Pharmacological Targeting of microglial activation: new therapeutic approach. Front Cell Neurosci 13:514","journal-title":"Front Cell Neurosci"},{"key":"4225_CR112","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","volume":"9","author":"SR Subramaniam","year":"2017","unstructured":"Subramaniam SR, Federoff HJ (2017) Targeting microglial activation states as a therapeutic avenue in Parkinson\u2019s disease. Front Aging Neurosci 9:176","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"4225_CR113","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11307-020-01485-w","volume":"22","author":"SJ Oh","year":"2020","unstructured":"Oh SJ, Ahn H, Jung KH, Han SJ, Nam KR, Kang KJ, Park JA, Lee KC, Lee YJ, Choi JY (2020) Evaluation of the neuroprotective effect of microglial depletion by CSF-1R inhibition in a Parkinson\u2019s animal model. Mol Imaging Biol 22(4):1031\u20131042","journal-title":"Mol Imaging Biol"},{"issue":"9","key":"4225_CR114","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.biopsych.2019.12.010","volume":"87","author":"N Ellis","year":"2020","unstructured":"Ellis N, Tee A, McAllister B, Massey T, McLauchlan D, Stone T, Correia K, Loupe J, Kim KH, Barker D et al (2020) Genetic risk underlying psychiatric and cognitive symptoms in Huntington\u2019s disease. Biol Psychiatry 87(9):857\u2013865","journal-title":"Biol Psychiatry"},{"key":"4225_CR115","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40","journal-title":"Orphanet J Rare Dis"},{"issue":"19","key":"4225_CR116","doi-asserted-by":"publisher","first-page":"e2045","DOI":"10.1212\/WNL.0000000000008906","volume":"94","author":"AM Glidden","year":"2020","unstructured":"Glidden AM, Luebbe EA, Elson MJ, Goldenthal SB, Snyder CW, Zizzi CE, Dorsey ER, Heatwole CR (2020) Patient-reported impact of symptoms in Huntington disease: PRISM-HD. Neurology 94(19):e2045\u2013e2053","journal-title":"Neurology"},{"key":"4225_CR117","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama TH, Waldvogel HJ, Faull RLM, Kwakowsky A (2019) The role of microglia and astrocytes in Huntington\u2019s disease. Front Mol Neurosci 12:258","journal-title":"Front Mol Neurosci"},{"key":"4225_CR118","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax3338","author":"M Barnat","year":"2020","unstructured":"Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, Kassem R, Lenoir S, Agasse F, Braz BY et al (2020) Huntington\u2019s disease alters human neurodevelopment. Science. https:\/\/doi.org\/10.1126\/science.aax3338","journal-title":"Science"},{"issue":"2","key":"4225_CR119","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ana.25647","volume":"87","author":"MR von Essen","year":"2020","unstructured":"von Essen MR, Hellem MNN, Vinther-Jensen T, Ammitzboll C, Hansen RH, Hjermind LE, Nielsen TT, Nielsen JE, Sellebjerg F (2020) Early intrathecal T helper 17.1 cell activity in Huntington disease. Ann Neurol 87(2):246\u2013255","journal-title":"Ann Neurol"},{"key":"4225_CR120","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00891-w","author":"D Dash","year":"2020","unstructured":"Dash D, Mestre TA (2020) Therapeutic update on Huntington\u2019s disease: symptomatic treatments and emerging disease-modifying therapies. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-020-00891-w","journal-title":"Neurotherapeutics"},{"key":"4225_CR121","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","volume":"83","author":"M Politis","year":"2015","unstructured":"Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P (2015) Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers. Neurobiol Dis 83:115\u2013121","journal-title":"Neurobiol Dis"},{"key":"4225_CR122","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fnagi.2017.00193","volume":"9","author":"HM Yang","year":"2017","unstructured":"Yang HM, Yang S, Huang SS, Tang BS, Guo JF (2017) Microglial activation in the pathogenesis of Huntington\u2019s disease. Front Aging Neurosci 9:193","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4225_CR123","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/awz363","volume":"143","author":"JD Crapser","year":"2020","unstructured":"Crapser JD, Ochaba J, Soni N, Reidling JC, Thompson LM, Green KN (2020) Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington\u2019s disease. Brain 143(1):266\u2013288","journal-title":"Brain"},{"issue":"1","key":"4225_CR124","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41366-019-0355-7","volume":"44","author":"TL Merry","year":"2020","unstructured":"Merry TL, Brooks AES, Masson SW, Adams SE, Jaiswal JK, Jamieson SMF, Shepherd PR (2020) The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice. Int J Obes (Lond) 44(1):245\u2013253","journal-title":"Int J Obes (Lond)"},{"key":"4225_CR125","doi-asserted-by":"crossref","first-page":"e12889","DOI":"10.1111\/adb.12889","volume":"26","author":"AS Warden","year":"2020","unstructured":"Warden AS, Triplett TA, Lyu A, Grantham EK, Azzam MM, DaCosta A, Mason S, Blednov YA, Ehrlich LIR, Mayfield RD et al (2020) Microglia depletion and alcohol: transcriptome and behavioral profiles. Addict Biol 26:e12889","journal-title":"Addict Biol"},{"issue":"1","key":"4225_CR126","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cr.2019.01.001","volume":"8","author":"S Yan","year":"2019","unstructured":"Yan S, Li S, Li XJ (2019) Use of large animal models to investigate Huntington\u2019s diseases. Cell Regen 8(1):9\u201311","journal-title":"Cell Regen"},{"issue":"7197","key":"4225_CR127","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J et al (2008) Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature 453(7197):921\u2013924","journal-title":"Nature"},{"issue":"4","key":"4225_CR128","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","volume":"173","author":"S Yan","year":"2018","unstructured":"Yan S, Tu Z, Liu Z, Fan N, Yang H, Yang S, Yang W, Zhao Y, Ouyang Z, Lai C et al (2018) A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease. Cell 173(4):989-1002 e1013","journal-title":"Cell"},{"issue":"2","key":"4225_CR129","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/mp.2016.220","volume":"22","author":"CM Sellgren","year":"2017","unstructured":"Sellgren CM, Sheridan SD, Gracias J, Xuan D, Fu T, Perlis RH (2017) Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors. Mol Psychiatry 22(2):170\u2013177","journal-title":"Mol Psychiatry"},{"issue":"8","key":"4225_CR130","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A, Grosskreutz J, Hardiman O, Henderson R, Matamala JM et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131(8):1975\u20131978","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"4225_CR131","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18(2):211\u2013220","journal-title":"Lancet Neurol"},{"issue":"2","key":"4225_CR132","doi-asserted-by":"publisher","first-page":"284","DOI":"10.7150\/ijbs.38487","volume":"16","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Zhu L, Qiu W, Liu Y, Yang F, Chen W, Xu R (2020) Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling in the brain of ALS SOD1(G93A) mice. Int J Biol Sci 16(2):284\u2013297","journal-title":"Int J Biol Sci"},{"key":"4225_CR133","doi-asserted-by":"publisher","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933","journal-title":"Neurosci Lett"},{"key":"4225_CR134","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fncel.2014.00131","volume":"8","author":"E Pollari","year":"2014","unstructured":"Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R (2014) The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci 8:131","journal-title":"Front Cell Neurosci"},{"key":"4225_CR135","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fnagi.2017.00242","volume":"9","author":"MC Geloso","year":"2017","unstructured":"Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D\u2019Ambrosi N (2017) The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci 9:242","journal-title":"Front Aging Neurosci"},{"key":"4225_CR136","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8:1005","journal-title":"Front Immunol"},{"issue":"1","key":"4225_CR137","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13041-020-00607-3","volume":"13","author":"H Komiya","year":"2020","unstructured":"Komiya H, Takeuchi H, Ogawa Y, Hatooka Y, Takahashi K, Katsumoto A, Kubota S, Nakamura H, Kunii M, Tada M et al (2020) CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in the lumbar spinal cord of ALS mice. Mol Brain 13(1):64","journal-title":"Mol Brain"},{"issue":"7","key":"4225_CR138","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s00259-016-3311-y","volume":"43","author":"S Gargiulo","year":"2016","unstructured":"Gargiulo S, Anzilotti S, Coda AR, Gramanzini M, Greco A, Panico M, Vinciguerra A, Zannetti A, Vicidomini C, Dolle F et al (2016) Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET\/CT. Eur J Nucl Med Mol Imaging 43(7):1348\u20131359","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"4225_CR139","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"BE Clarke","year":"2020","unstructured":"Clarke BE, Patani R (2020) The microglial component of amyotrophic lateral sclerosis. Brain 143(12):3526\u20133539","journal-title":"Brain"},{"issue":"1","key":"4225_CR140","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-020-01822-4","volume":"17","author":"E Christoforidou","year":"2020","unstructured":"Christoforidou E, Joilin G, Hafezparast M (2020) Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis. J Neuroinflammation 17(1):135","journal-title":"J Neuroinflammation"},{"key":"4225_CR141","doi-asserted-by":"publisher","first-page":"113259","DOI":"10.1016\/j.expneurol.2020.113259","volume":"328","author":"Y Du","year":"2020","unstructured":"Du Y, Zhao W, Thonhoff JR, Wang J, Wen S, Appel SH (2020) Increased activation ability of monocytes from ALS patients. Exp Neurol 328:113259","journal-title":"Exp Neurol"},{"key":"4225_CR142","doi-asserted-by":"publisher","first-page":"25663","DOI":"10.1038\/srep25663","volume":"6","author":"A Martinez-Muriana","year":"2016","unstructured":"Martinez-Muriana A, Mancuso R, Francos-Quijorna I, Olmos-Alonso A, Osta R, Perry VH, Navarro X, Gomez-Nicola D, Lopez-Vales R (2016) CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Sci Rep 6:25663","journal-title":"Sci Rep"},{"issue":"11","key":"4225_CR143","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41593-020-00718-z","volume":"23","author":"A Chiot","year":"2020","unstructured":"Chiot A, Zaidi S, Iltis C, Ribon M, Berriat F, Schiaffino L, Jolly A, de la Grange P, Mallat M, Bohl D et al (2020) Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat Neurosci 23(11):1339\u20131351","journal-title":"Nat Neurosci"},{"issue":"10","key":"4225_CR144","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jnr.24023","volume":"95","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Sun L, Xie Z, Fan X, Cao Q, Han J, Zhu J, Jin T (2017) Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications. J Neurosci Res 95(10):1973\u20131983","journal-title":"J Neurosci Res"},{"key":"4225_CR145","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520975323","author":"R Ramanujam","year":"2020","unstructured":"Ramanujam R, Zhu F, Fink K, Karrenbauer VD, Lorscheider J, Benkert P, Kingwell E, Tremlett H, Hillert J, Manouchehrinia A et al (2020) Accurate classification of secondary progression in multiple sclerosis using a decision tree. Mult Scler. https:\/\/doi.org\/10.1177\/1352458520975323","journal-title":"Mult Scler"},{"issue":"3","key":"4225_CR146","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/WCO.0000000000000811","volume":"33","author":"PS Sorensen","year":"2020","unstructured":"Sorensen PS, Fox RJ, Comi G (2020) The window of opportunity for treatment of progressive multiple sclerosis. Curr Opin Neurol 33(3):262\u2013270","journal-title":"Curr Opin Neurol"},{"key":"4225_CR147","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2018","unstructured":"Lassmann H (2018) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116","journal-title":"Front Immunol"},{"issue":"21","key":"4225_CR148","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.3390\/ijms21218217","volume":"21","author":"S Monaco","year":"2020","unstructured":"Monaco S, Nicholas R, Reynolds R, Magliozzi R (2020) Intrathecal inflammation in progressive multiple sclerosis. Int J Mol Sci 21(21):8217","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4225_CR149","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet S, Prinz M, van Loo G (2019) Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med 25(2):112\u2013123","journal-title":"Trends Mol Med"},{"issue":"2","key":"4225_CR150","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/RLU.0000000000003398","volume":"46","author":"T Singhal","year":"2021","unstructured":"Singhal T, Rissanen E, Ficke J, Cicero S, Carter K, Weiner HL (2021) Widespread glial activation in primary progressive multiple sclerosis revealed by 18F-PBR06 PET: a clinically feasible, individualized approach. Clin Nucl Med 46(2):136\u2013137","journal-title":"Clin Nucl Med"},{"issue":"6","key":"4225_CR151","doi-asserted-by":"publisher","first-page":"10576","DOI":"10.1002\/jcb.28344","volume":"120","author":"F Tahmasebi","year":"2019","unstructured":"Tahmasebi F, Pasbakhsh P, Mortezaee K, Madadi S, Barati S, Kashani IR (2019) Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model. J Cell Biochem 120(6):10576\u201310586","journal-title":"J Cell Biochem"},{"key":"4225_CR152","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2018.05.021","volume":"307","author":"JC Nissen","year":"2018","unstructured":"Nissen JC, Thompson KK, West BL, Tsirka SE (2018) Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery. Exp Neurol 307:24\u201336","journal-title":"Exp Neurol"},{"issue":"10","key":"4225_CR153","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.it.2015.08.008","volume":"36","author":"Y Wu","year":"2015","unstructured":"Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B (2015) Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol 36(10):605\u2013613","journal-title":"Trends Immunol"},{"key":"4225_CR154","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.bbi.2018.07.023","volume":"73","author":"JM Rosin","year":"2018","unstructured":"Rosin JM, Vora SR, Kurrasch DM (2018) Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour. Brain Behav Immun 73:682\u2013697","journal-title":"Brain Behav Immun"},{"issue":"10","key":"4225_CR155","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/jnr.24641","volume":"98","author":"X Ma","year":"2020","unstructured":"Ma X, Chen K, Cui Y, Huang G, Nehme A, Zhang L, Li H, Wei J, Liong K, Liu Q et al (2020) Depletion of microglia in developing cortical circuits reveals its critical role in glutamatergic synapse development, functional connectivity, and critical period plasticity. J Neurosci Res 98(10):1968\u20131986","journal-title":"J Neurosci Res"},{"issue":"1","key":"4225_CR156","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1038\/s41467-018-05929-4","volume":"9","author":"SJ Rubino","year":"2018","unstructured":"Rubino SJ, Mayo L, Wimmer I, Siedler V, Brunner F, Hametner S, Madi A, Lanser A, Moreira T, Donnelly D et al (2018) Acute microglia ablation induces neurodegeneration in the somatosensory system. Nat Commun 9(1):4578","journal-title":"Nat Commun"},{"key":"4225_CR157","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50531","author":"J Wallace","year":"2020","unstructured":"Wallace J, Lord J, Dissing-Olesen L, Stevens B, Murthy VN (2020) Microglial depletion disrupts normal functional development of adult-born neurons in the olfactory bulb. Elife. https:\/\/doi.org\/10.7554\/eLife.50531","journal-title":"Elife"},{"key":"4225_CR158","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.expneurol.2019.04.011","volume":"318","author":"Y Liu","year":"2019","unstructured":"Liu Y, Given KS, Dickson EL, Owens GP, Macklin WB, Bennett JL (2019) Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo. Exp Neurol 318:32\u201341","journal-title":"Exp Neurol"},{"issue":"21","key":"4225_CR159","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.7150\/thno.44394","volume":"10","author":"D Kerkhofs","year":"2020","unstructured":"Kerkhofs D, van Hagen BT, Milanova IV, Schell KJ, van Essen H, Wijnands E, Goossens P, Blankesteijn WM, Unger T, Prickaerts J et al (2020) Pharmacological depletion of microglia and perivascular macrophages prevents vascular cognitive impairment in Ang II-induced hypertension. Theranostics 10(21):9512\u20139527","journal-title":"Theranostics"},{"issue":"2\u20134","key":"4225_CR160","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.imbio.2005.05.005","volume":"210","author":"S Wei","year":"2005","unstructured":"Wei S, Lightwood D, Ladyman H, Cross S, Neale H, Griffiths M, Adams R, Marshall D, Lawson A, McKnight AJ et al (2005) Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. Immunobiology 210(2\u20134):109\u2013119","journal-title":"Immunobiology"},{"issue":"1","key":"4225_CR161","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12974-020-01832-2","volume":"17","author":"EG Vichaya","year":"2020","unstructured":"Vichaya EG, Malik S, Sominsky L, Ford BG, Spencer SJ, Dantzer R (2020) Microglia depletion fails to abrogate inflammation-induced sickness in mice and rats. J Neuroinflammation 17(1):172","journal-title":"J Neuroinflammation"},{"issue":"15","key":"4225_CR162","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood-2012-04-425595","volume":"120","author":"V Chitu","year":"2012","unstructured":"Chitu V, Nacu V, Charles JF, Henne WM, McMahon HT, Nandi S, Ketchum H, Harris R, Nakamura MC, Stanley ER (2012) PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood 120(15):3126\u20133135","journal-title":"Blood"},{"key":"4225_CR163","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/DDDT.S253232","volume":"14","author":"B Benner","year":"2020","unstructured":"Benner B, Good L, Quiroga D, Schultz TE, Kassem M, Carson WE, Cherian MA, Sardesai S, Wesolowski R (2020) Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic review of pre-clinical and clinical development. Drug Des Devel Ther 14:1693\u20131704","journal-title":"Drug Des Devel Ther"},{"issue":"10197","key":"4225_CR164","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","volume":"394","author":"WD Tap","year":"2019","unstructured":"Tap WD, Gelderblom H, Palmerini E, Desai J, Bauer S, Blay JY, Alcindor T, Ganjoo K, Martin-Broto J, Ryan CW et al (2019) Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet 394(10197):478\u2013487","journal-title":"Lancet"},{"issue":"2","key":"4225_CR165","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/glia.23539","volume":"67","author":"J Groh","year":"2019","unstructured":"Groh J, Klein D, Berve K, West BL, Martini R (2019) Targeting microglia attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations. Glia 67(2):277\u2013290","journal-title":"Glia"},{"issue":"29","key":"4225_CR166","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2217\/fon-2020-0542","volume":"16","author":"H Gelderblom","year":"2020","unstructured":"Gelderblom H, de Sande MV (2020) Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumor. Future Oncol 16(29):2345\u20132356","journal-title":"Future Oncol"},{"key":"4225_CR167","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00549-18","author":"JA Carroll","year":"2018","unstructured":"Carroll JA, Race B, Williams K, Striebel J, Chesebro B (2018) Microglia are critical in host defense against prion disease. J Virol. https:\/\/doi.org\/10.1128\/JVI.00549-18","journal-title":"J Virol"},{"issue":"2","key":"4225_CR168","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/all.14011","volume":"75","author":"HG Moon","year":"2020","unstructured":"Moon HG, Kim SJ, Lee MK, Kang H, Choi HS, Harijith A, Ren J, Natarajan V, Christman JW, Ackerman SJ et al (2020) Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma. Allergy 75(2):357\u2013369","journal-title":"Allergy"},{"issue":"3","key":"4225_CR169","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s13365-019-00740-3","volume":"25","author":"JMS Sanchez","year":"2019","unstructured":"Sanchez JMS, DePaula-Silva AB, Doty DJ, Truong A, Libbey JE, Fujinami RS (2019) Microglial cell depletion is fatal with low level picornavirus infection of the central nervous system. J Neurovirol 25(3):415\u2013421","journal-title":"J Neurovirol"},{"issue":"3","key":"4225_CR170","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1172\/JCI97229","volume":"128","author":"DL Wheeler","year":"2018","unstructured":"Wheeler DL, Sariol A, Meyerholz DK, Perlman S (2018) Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest 128(3):931\u2013943","journal-title":"J Clin Invest"},{"key":"4225_CR171","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01428-20","author":"O Uyar","year":"2020","unstructured":"Uyar O, Laflamme N, Piret J, Venable MC, Carbonneau J, Zarrouk K, Rivest S, Boivin G (2020) An early microglial response is needed to efficiently control herpes simplex virus encephalitis. J Virol. https:\/\/doi.org\/10.1128\/JVI.01428-20","journal-title":"J Virol"},{"issue":"6","key":"4225_CR172","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/mds.28627","volume":"36","author":"J Han","year":"2021","unstructured":"Han J, Harris RA, Karrenbauer VD (2021) Chronic immunosuppression and potential infection risks in CSF1R-related leukoencephalopathy. Mov Disord 36(6):1470\u20131471","journal-title":"Mov Disord"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04225-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:27:55Z","timestamp":1700389675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04225-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ZKW serves as PI or Co-PI on Biogen, Inc. (228PD201), Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), and Neuraly, Inc. (NLY01-PD-1) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research. VDK Biogen (recipient of grant and scholarship, PI for project sponsored by); Novartis (Scientific Advisory board member, recipient of scholarship and lecture honoraria); Merc (Scientific Advisory Board member, recipient of lecture honoraria), Neuro Vigil (Scientific Advisory Board member).\u00a0VDK has received financial support from Stockholm County Council (Grant ALF 20160457), Biogen (recipient of grant and scholarship, PI for the project sponsored by Biogen); Novartis (Scientific Advisory Board member, recipient of scholarship and lecture honoraria) and Merck (Scientific Advisory Board member, recipient of lecture honoraria).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"219"}}